Kathleen Stringer Earns Prestigious Therapeutic Frontiers Lecture Award
Kathleen Stringer, PharmD’85, FCCP, has been selected by the American College of Clinical Pharmacy (ACCP) to deliver the association’s prestigious 2022 Therapeutic Frontiers Lecture. The award and lecture will be presented in San Francisco, California, on Sunday, October 16, during the ACCP Global Conference on Clinical Pharmacy awards and recognition ceremony.
According to ACCP, the Therapeutic Frontiers Lecture Award recognizes an individual, including ACCP member and nonmember nominees, who have made outstanding contributions to pharmacotherapeutics in their field. Among the criteria for this award is the broad acknowledgment that the recipient is currently considered to be at the leading edge of research in the field.
“Dr. Stringer is so deserving of this award,” says Vicki Ellingrod, PharmD, FCCP, FACNP, Dean and John Gideon Searle Professor of Pharmacy. “She is a long-standing leader in the field of sepsis and her innovative examination of how to identify and treat those with this critical illness will ultimately result in better patient outcomes, including reduced mortality."
Dr. Stringer is the Albert B. Prescott Collegiate Professor of Clinical and Translational Pharmacy, College of Pharmacy and Professor, Internal Medicine, Pulmonary and Critical Care Medicine, School of Medicine, at the University of Michigan. She also serves as the director of the NMR Metabolomics Laboratory and is a Deputy Director of the Weil Institute for Critical Care Research and Innovation. She leads a research program in Translational Metabolomics in Critical Care which is funded by an NIH Maximizing Investigators' Research Award (R35).
Dr. Stringer received her PharmD degree from the University of Michigan in 1985, did her clinical residency at the University of Illinois at Chicago and completed fellowships at both the State University of New York - Buffalo and the University of Colorado Health Sciences Center in Denver. She was a faculty member in the School of Pharmacy at the University of Colorado for nearly 20 years before joining the faculty of the University of Michigan College of Pharmacy in 2007. She mentors numerous students and trainees across pharmacy and medicine disciplines and was a recipient of the Michigan Institute for Clinical and Health Research Distinguished Mentor Award in 2014. Dr. Stringer was appointed to the editorial board of Pharmacotherapy in 2015 and became a scientific editor in 2018. She oversees manuscripts that address a broad range of topics in critical care.
Dr. Stringer’s lecture, Sepsis is a metabolic disease: evidence from metabolomics and pharmacometabolomics, will focus on new and emerging data that support the metabolic underpinnings of sepsis and how these data can be used to subphenotype sepsis patients, identify new drug target opportunities, and assess drug response.